WT1 and leukemia: The lower specificity of post-SCT MRD by FCM compared to WT1 may be attributed to the presence of leukemia-associated immunophenotypes in regenerating bone marrow cells, reducing the sensitivity of aberrant phenotypes in identifying leukemic cells [27].